Fisher & Paykel Healthcare Corporation Limited Share Price

Equities

FPH

NZFAPE0001S2

Medical Equipment, Supplies & Distribution

End-of-day quote New Zealand S.E. 23:00:00 30/05/2024 BST 5-day change 1st Jan Change
29.5 NZD +3.51% Intraday chart for Fisher & Paykel Healthcare Corporation Limited +4.13% +25.00%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2025 * 1.96B 1.2B 94.36B Sales 2026 * 2.18B 1.34B 105B Capitalization 17.23B 10.58B 831B
Net income 2025 * 340M 209M 16.4B Net income 2026 * 410M 252M 19.78B EV / Sales 2025 * 8.79 x
Net cash position 2025 * 28.79M 17.69M 1.39B Net cash position 2026 * 31.74M 19.5M 1.53B EV / Sales 2026 * 7.89 x
P/E ratio 2025 *
50.6 x
P/E ratio 2026 *
42.1 x
Employees 7,005
Yield 2025 *
1.49%
Yield 2026 *
1.66%
Free-Float 90.59%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Fisher & Paykel Healthcare Corporation Limited

1 day+3.51%
1 week+4.13%
1 month+4.94%
3 months+19.34%
6 months+23.90%
Current year+25.00%
More quotes
1 week
27.51
Extreme 27.51
29.73
1 month
27.51
Extreme 27.51
29.73
Current year
22.55
Extreme 22.55
29.73
1 year
20.29
Extreme 20.29
29.73
3 years
18.02
Extreme 18.02
34.55
5 years
14.85
Extreme 14.85
37.89
10 years
4.43
Extreme 4.43
37.89
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 31/12/84
Director of Finance/CFO - 28/02/19
Chief Tech/Sci/R&D Officer - 31/07/14
Members of the board TitleAgeSince
Director/Board Member 66 30/04/90
Chairman - 30/09/15
Chief Executive Officer 63 31/12/84
More insiders
Date Price Change Volume
31/05/24 29.5 +3.51% 2,503,958
30/05/24 28.5 -0.87% 417,587
29/05/24 28.75 +3.94% 657,795
28/05/24 27.66 -1.39% 286,642
27/05/24 28.05 -0.99% 107,346

End-of-day quote New Zealand S.E., May 30, 2024

More quotes
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India and others.
Related indices
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
29.5 NZD
Average target price
26.11 NZD
Spread / Average Target
-11.48%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW